LLLan Lin

Lan Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lan Lin has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Chunyan Hu

    Department of Clinical Pathology, Eye & ENT Hospital, Fudan University, Shanghai, China

    4 shared publications
  • Chunyan Hu

    Department of Biochemistry and Molecular Biology, Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai, China

    4 shared publications
  • Huan Wang

    ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

    3 shared publications
  • Qiang Huang

    Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

    3 shared publications
  • Dehui Wang

    Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

    2 shared publications
  • Feiran Li

    Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

    2 shared publications

Latest Publications

  • NUT Carcinoma of the Head and Neck: Clinicopathologic and Molecular Analysis of 18 Cases

    by Yifeng Liu, Cuncun Yuan, Ji Sun, Jiahao Zhang, Lan Lin, Jifeng Gu, Chunyan Hu

    Purpose NUT carcinoma (NC) is a rare, aggressive neoplasm with limited therapeutic options. This study aimed to delineate the clinicopathologic and molecular characteristics of head and neck NC (HNNC) to refine diagnostic strategies and identify prognostic factors. Methods and Results We conducted a retrospective analysis of 18 HNNC cases from a single institution (2015–2024). Our cohort consisted of 7 males and 11 females, aged 14–72 years (mean: 45 years), with the predominant site of involvement being the sinonasal tract (77.8%), followed by the larynx (16.7%) and the nasopharynx (5.5%). Microscopically, HNNCs typically grew as nests and sheets of poorly differentiated cells with focal or extensive abrupt keratinization. Several cases also displayed distinct morphological variants, including spindle cell components (4/18), basaloid (1/18), ameloblastic-like (1/18), papillary structures (1/18), monomorphic cell clusters (1/18), and concentric pattern around blood vessels (2/18). All cases were moderately to strongly positive for NUT protein (H-score: 80 to 300). PD-L1 was expressed in 43.8% of tumors (7/16). FISH confirmed NUTM1 rearrangement in 15 cases (15/16, 93.8%), and RNA sequencing analysis of 14 cases revealed the following fusion patterns: NUTM1::BRD4 (10/14, 71.4%), NUTM1::BRD3 (3/14, 21.4%), and NUTM1::NSD3 (1/14, 7.1%). Follow-up data were available for 17 patients (range: 2–52 months), among whom 10 patients died of the disease. The median overall survival was 12 months. Conclusions This large single-center series confirms that HNNC exhibits marked morphological heterogeneity and poor prognosis. Accurate diagnosis relies on immunohistochemistry, with FISH and RNA sequencing as needed, offering molecular insights to guide prognosis and clinical management.


  • Clinical and Histopathologic Analyses of Nasopharyngeal Hyalinizing Clear Cell Carcinoma

    by Changwen Mm Zhai, Cuncun Mm Yuan, Ji Mm Sun, Wanjing Mm Song, Shuyi Mm Wang, Lan Mm Lin

    The aim of this study was to evaluate the clinicopathologic features, molecular characteristics, treatment strategy, and prognosis of nasopharyngeal hyalinizing clear cell carcinoma (HCCC). Retrospective observational case series. Institutional pathology records between 2006 and 2022 were searched for all cases of nasopharyngeal HCCC. We included 10 male and 16 female patients aged 30 to 82 years (median: 60.5 y, mean: 54.6 y). The most common symptoms were blood-stained rhinorrhea and nasal obstruction. Tumors most often involved the lateral wall of the nasopharynx, followed by the superior posterior wall. Microscopically, all tumor cells were arranged in sheets, nests, cords, and single cells in a hyaline/myxoid/fibrous stroma. The tumor cells were polygonal, with or without distinct cell borders, and displayed abundant clear-to-eosinophilic cytoplasm. All 26 cases were positive for pancytokeratin, CK7, p40, and p63 but negative for myoepithelial differentiation markers. Ki-67 labeling was low and ranged from 1% to 10%. All 26 cases demonstrated EWSR1 and EWSR1-ATF1 rearrangements, and no case demonstrated MAML2 rearrangement. Complete follow-up data were available for 23 patients: 14 patients underwent endoscopic surgery alone, 5 underwent radiation therapy followed by endoscopic surgery, 3 underwent radiation therapy followed by biopsy, and 1 underwent cisplatin chemotherapy before endoscopic surgery. Clinical follow-up ranged from 6 to 195 months; 13 patients (56.5%) were alive without tumor, 5 patients (21.7%) died of disease, 5 patients (21.7%) survived with tumor. HCCCs of the nasopharynx are rare tumors. The definitive diagnosis depends on histopathology, immunohistochemistry, and molecular studies. The optimal treatment for patients with nasopharyngeal HCCC is wide local excision. Radiation and chemotherapy might be good options for managing locally advanced cases. Nasopharyngeal HCCC is less indolent than previously thought. Tumor stage and the choice of treatment are key factors affecting the prognosis of nasopharyngeal HCCC patients.


  • Open Access

    Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study

    by Qiang Huang, Feiran Li, Mengyou Ji, Lan Lin, Chunyan Hu

    Purpose: To evaluate prognostic significance of human papillomavirus (HPV) in hypopharyngeal squamous cell carcinoma patients, and to investigate the effect of p53 and TP53 mutations on the prognosis of patients. Methods: A total of 111 patients were enrolled in our retrospective study. HPV infection status was detected in formalin-fixed paraffin-embedded tissue by real-time multiplex PCR test. p53 expression was evaluate by immunohistochemical staining. TP53 exon mutations were analyzed by PCR amplification and Sanger sequencing. HPV infection status, p53 expression and TP53 mutation were compared with clinical outcome including overall survival and recurrence-free survival by Kaplan-Meier method and Log-rank test. Results: Of the 111 investigated patients, 18 (16.22%) were positive for HPV infection. HPV(-) patients have a worse clinical outcome than HPV(+) patients. TP53 mutations have similar mutation rates in patients with and without HPV (55.56% vs. 41.94%). p53 and TP53 mutation were not associated with prognosis of patients in HPV(-) patients. TP53 disruptive mutations were found both in patients with or without HPV infection. Furthermore, TP53 non-disruptive mutation had a significantly better clinical outcome than those with disruptive mutation in HPV(-) patients. Conclusion: Our results showed that HPV infection status is a strong prognostic indicator of survival. p53 and TP53 mutations do not appear to significantly impact survival in HPV(-) patients. TP53 disruptive mutation is associated with reduced survival in HPV(-)/TP53 mutation patients.


  • Open Access

    Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell Carcinoma

    by Qiang Huang, Yu-Jie Shen, Chi-Yao Hsueh, Yi-Fan Zhang, Xiao-Hui Yuan, Yu-Juan Zhou, Jiao-Yu Li, Lan Lin, Chun-Ping Wu, Chun-Yan Hu

    Purpose: This study aimed to investigate the applicability of plasma extracellular vesicles (EVs) miR-99a-5p as a potential head and neck squamous cell carcinoma (HNSCC) diagnostic biomarker.Methods: The miRNA expression of HNSCC tissue and plasma EVs were profiled by small RNA sequencing. qRT-PCR was performed to detect miR-99a-5p expression in HNSCC (n = 93) and benign disease (n = 39) plasma EVs and formalin-fixed and paraffin-embedded (FFPE) tissue (n = 110). We constructed receiver-operating characteristic curves to investigate the diagnostic efficiency of plasma EVs miR-99a-5p.Results: Tumor tissue exhibited lower miR-99a-5p than para-tumor tissue. Patients with high miR-99a-5p expression exhibited significantly more p16 positive status. In contrast, HNSCC plasma EVs harbored more miR-99a-5p than the benign disease group. Plasma EVs miR-99a-5p distinguished HNSCC with area under the curve (AUC) of 0.7494 (95% CI: 0.6692–0.8296; p < 0.0001), with 61.54% sensitivity and 75.27% specificity, respectively. Furthermore, plasma EVs miR-99a-5p also distinguished early HNSCC with AUC of 0.7394 (95% CI: 0.6284–0.8504; p = 0.0002), with 79.07% sensitivity and 61.54% specificity, respectively.Conclusion: Plasma EVs miR-99a-5p is a potential biomarker for predicting early HNSCC.


  • Open Access

    Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: a 3-year follow-up retrospective study

    by Qiang Huang, Min Ye, Feiran Li, Lan Lin, Chunyan Hu

    Purpose: To investigate the expression and prognostic value of c-Jun in hypopharyngeal squamous cell carcinoma (HPSCC). Methods: A retrospective study was performed on a cohort of 99 HPSCC patients. The expression of c-Jun and phosphorylated-c-Jun (p-c-Jun) was evaluated via immunohistochemistry (IHC) staining. Overall survival (OS) and progression-free survival (PFS) were assessed using Kaplan–Meier method and multivariate Cox regression analysis. Results: The high expression of c-Jun and p-c-Jun in HPSCC accounted for 60.61% and 16.16%, respectively. High expression of c-Jun was closely associated with cT stage (p = 0.0401), tumor size (p = 0.0276), number of lymph node metastases (p = 0.0205) and pathological differentiation (p = 0.0108). The expression of c-Junhigh (p = 0.0043), p-c-Junhigh (p = 0.0376) and c-Junhigh/p-c-Junhigh were closely associated with poor OS. The Cox proportional multivariate hazard model revealed that lymphovascular invasion and c-Jun expression were independent influencing factors of OS in HPSCC patients. Conclusion: Our findings suggest that c-Jun is a reliable prognostic factors in HPSCC patients.


  • Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma

    by Huan Wang, Changwen Zhai, Chen Zhang, Quan Liu, Huankang Zhang, Xicai Sun, Lan Lin, Hongmeng Yu, Dehui Wang


  • Open Access

    Prevalence of human papillomavirus in sinonasal squamous cell carcinoma with and without association of inverted papilloma in Eastern China

    by Chunyan Hu, Huatao Quan, Li Yan, Ji Sun, Lin Lan, Shengzi Wang

    Background: Information on HPV-associated sinonasal squamous cell carcinoma (SNSCC) is very limited in China. The aim of this study was to determine the prevalence of HPV in a large cohort of SNSCC patients in China. Methods: Clinical records and formalin-fixed and paraffin-embedded tumor specimens from 30 SNSCC patients with associated inverted papilloma (IP-SNSCC) and 84 de novo SNSCC (DN-SNSCC) patients were retrieved between 2010 and 2017. HPV status was determined for each specimen using a combination of p16 immunohistochemistry and GP5+/6+ PCR. Results: Immunohistochemistry for p16 was positive in two IP-SNSCC patients (2/30, 6.7%) and in 16 DN-SNSCC patients (16/84, 19.0%). HPV DNA was detected in six IP-SNSCC patients (6/30, 20%) and in three DN-SNSCC patients (3/84, 3.8%). Expression of p16 was not correlated with the presence of HPV DNA (p = 0.150). Among 18 p16-positive SNSCC patients, only three were HPV DNA-positive. Furthermore, only three of nine HPV DNA-positive tumors exhibited high p16 expression. In IP-SNSCC patients, only one of six HPV DNA-positive tumors exhibited high p16 expression. In DN-SNSCC patients, two of three HPV DNA-positive tumors exhibited high p16 expression. The positive rates for both HPV DNA and p16 in IP-SNSCC patients and DN-SNSCC patients were 3.3 and 2.4%, respectively. Conclusions: Immunostaining for p16 is not a reliable surrogate marker of HPV status in SNSCC. The presence of HPV is rarely detected in DN-SNSCC patients in Eastern China. IP-SNSCC patients frequently lack of p16 overexpression despite the presence of high-risk HPV DNA.


  • Open Access

    Association between Carbonic anhydrase 9 expression and poor prognosis in sinonasal squamous cell carcinoma

    by Lan Lin, Chunyan Hu, Huan Wang, Xicai Sun, Dehui Wang

    Background: Carbonic anhydrase 9(CA9), as a member of the carbonic anhydrase enzyme family, was an endogenous marker of hypoxia. Previous studies suggested CA9 expression was correlated with poor prognosis in multiple types of malignancies. The purpose of current study was to evaluate the role of CA9 as a prognostic marker in sinonasal squamous cell carcinoma(SNSCC).Patients and methods: We assessed the immunohistochemical expression of CA9 in 63 tumor specimens of patients who underwent curative surgery and evaluated the relationship between the expression levels and clinicopathological factors as well as outcome.Results: We observed positive expression of CA9 in 21(33.3%) patients. Positive expression of CA9 in patients with SNSCC was significantly correlated with local recurrence (p=0.016) and both overall survival (OS) (p=0.003) and disease-free survival (DFS) (p=0.002). In Cox's multivariate analysis, CA9 expression was an independent negative prognostic factor for OS (p=0.027) and DFS (p=0.018).Conclusions: Our findings demonstrated that CA9 overexpression could be used as an independent prognostic biomarker and therapeutic target in SNSCC.